Key takeaways
- Good-fit accounts sit quiet for months, then something changes. That's the moment to reach out.
- The cues to move: new budget, a hire in a role you sell into, or a new problem to solve.
- Signals don't all stay useful for the same length of time. A demo request needs a same-day reply, while a funding round signal may still be live weeks later.
Fit tells you who to target. It does not tell you when. Reach out at the wrong moment on a genuinely good-fit account and you get a polite non-response, and a warm account cools off for no good reason.
Fit tells you who; readiness tells you when
Readiness is what separates "a company we should eventually sell to" from "something just happened that makes this month a better time to reach out than last month." It is built from public events, each one pointing at a concrete change inside the account.
The cues that mean it's time
A readiness signal is really one of a few concrete changes. Whether it is a funding round, a hire, an FDA milestone, or a conference booking, each one points at one of these:
Money to spend just showed up: a funding round, a grant, a milestone payment. The clearest sign a purchase is even possible.
Work just got more complex: a trial moving to the next phase, an FDA milestone, a new or expanding facility. A real problem now exists that you might be the one to solve.
A new buyer or team is in place: a relevant hire, a promotion, a contact who just changed roles or companies. New people usually means existing vendor relationships are back up for review.
The company’s direction or program mix just changed: a licensing deal, a co-development agreement, a move toward commercial launch. Priorities are moving.
Why timing beats persistence
A good-fit account with nothing happening is not a "no," it is a "not yet." The instinct on a strong account that has gone quiet is to reach out anyway, on a schedule, because it feels productive. In practice that produces a string of low-response messages and can wear out a relationship that would have answered well once a real reason to talk appeared. The better default is to keep the account on a watch list and move the moment a real signal shows up.
Signals decay, and not all at the same rate
A signal's relevance fades over time, but how fast depends heavily on what kind of event it is:
- First-party, high-urgency signals such as a demo request or an inbound enquiry are the most time-sensitive of all; responding as close to same-day as possible matters far more here than for any other signal type.
- Hiring and role-change signals, like a new hire, a promotion, or a job change, tend to stay strongest in the first one to a few months after the event, while the new person or team is still settling in and forming opinions about vendors.
- Funding and major strategy signals, like a raise, a licensing deal, or an M&A event, tend to persist much longer, often most of a year, because the resulting budget or strategic shift plays out over an extended period rather than a single moment.
- Clinical and regulatory milestones, like a phase transition or an FDA approval, are usually strongest right around the milestone itself and in the months that follow, then gradually lose relevance as the program moves on to its next stage.
- Visibility and research signals, like a conference appearance or a publication, have the shortest useful shelf life, typically a few weeks, since their value is mostly in giving an outreach message a timely, specific hook.
The takeaway: how long you can wait depends on the signal type, not one blanket rule like "anything older than X days is stale."
Signals compound
Confidence goes up when several of these cues land together on the same account, because it usually means a real, company-wide shift rather than a one-off: budget arriving alongside a new need, or a strategy change bringing in new people.
See which signals actually matter in biotech and pharma for the full catalog these cues are built from.
A simple rule for cadence
In practice the rule is simple: move quickly once a real signal lands on a good-fit account, and resist the urge to manufacture activity on accounts that have not moved.